View Older Stories View More Recent Stories
-
IOVA FRAUD NOTICE: Iovance Biotherapeutics, Inc. Shareholders that Lost Money are Reminded to Contact BFA Law by the July 14 Securities Fraud Class Action Deadline
-
Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
-
IOVA COURT ALERT: Investors of Iovance Biotherapeutics, Inc. that Lost Money are Notified to Contact BFA Law by July 14 Class Action Deadline
-
Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure- Hagens Berman
-
IOVA REMINDER: Iovance Biotherapeutics, Inc. Investors are Reminded to Contact BFA Law by July 14 Securities Fraud Class Action Deadline
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA
-
Scott+Scott Attorneys at Law LLP Reminds Investors a Securities Class Action Was Filed Against Iovance Biotherapeutics, Inc. (IOVA)
-
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
-
IOVA ALERT: Iovance Biotherapeutics, Inc. Shareholders with Losses are Alerted to Contact BFA Law before July 14 Class Action Deadline
-
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Iovance's (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit - Hagens Berman
-
Scott+Scott Attorneys at Law LLP Again Alerts Investors of The Pending Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
-
IOVA SHAREHOLDER NOTICE: BFA Law Alerts Iovance Biotherapeutics, Inc. Investors to Contact the Firm before Expiration of July 14 Class Action Deadline
-
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
-
Scott+Scott Attorneys at Law LLP Alerts Investors of The Pending Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
-
IOVA CLASS ACTION NEWS: Iovance Biotherapeutics, Inc. Shareholders that Suffered Losses are Alerted of the Upcoming July 14 Securities Fraud Class Action Deadline
-
ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA
-
IOVA LEGAL ALERT: BFA Law Notifies Iovance Biotherapeutics, Inc. Investors of the Imminent July 14 Securities Fraud Class Action Deadline
-
Scott+Scott Attorneys at Law LLP Again Alerts Investors of The Pending Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance's (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit - Hagens Berman
-
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
IOVA LEGAL NEWS: Iovance Biotherapeutics, Inc. Investors with Losses are Notified to Contact BFA Law about the Pending Class Action Lawsuit
-
Scott+Scott Attorneys at Law LLP Reminds Investors of The Pending Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
-
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
-
IOVA INVESTOR REMINDER: BFA Law Reminds Iovance Biotherapeutics, Inc. Investors to Contact the Firm by the July 14 Class Action Deadline
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
-
Faruqi & Faruqi Reminds Iovance Biotherapeutics of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025 - IOVA
-
IOVA INVESTOR ALERT: Iovance Biotherapeutics, Inc. Shareholders are Notified to Contact BFA Law by the July 14 Securities Fraud Class Action Deadline
-
Scott+Scott Attorneys at Law LLP Continues to Remind Investors of The Ongoing Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
-
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - IOVA
-
IOVA LAWSUIT DEADLINE: BFA Law Notifies Iovance Biotherapeutics, Inc. Investors to Contact the Firm before the July 14 Securities Class Action Deadline
-
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Scott+Scott Attorneys at Law LLP Alerts Investors of the Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA
-
Iovance's (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit- Hagens Berman
-
IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
IOVA STOCK NEWS: Iovance Biotherapeutics, Inc. Shareholders are Reminded of the Upcoming July 14 Securities Class Action Deadline
-
Goldman Sachs Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)
-
H.C. Wainwright Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)
-
Citizens JMP Reiterates Market Perform Rating on Iovanace Biotherapeutics (IOVA)
-
Scott+Scott Attorneys at Law LLP Continues to Remind Investors There is a Securities Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics (IOVA) Announces Publication on Amtagvi
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
-
IOVA CLASS ALERT: Iovance Biotherapeutics, Inc. Investors with Losses are Notified to Contact BFA Law about the Securities Fraud Class Action
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA
-
Scott+Scott Attorneys at Law LLP Reminds Investors of The Securities Class Action That Has Been Filed Against Iovance Biotherapeutics, Inc. (IOVA)
-
IOVA DEADLINE: BFA Law Alerts Iovance Biotherapeutics, Inc. Investors of the Pending July 14 Class Action Deadline
-
Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025

